Buddha North War Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Park Shishan area to the next city! On March 1, the great health industry and epidemic prevention science and Technology Park project successfully obtained 238.73 mu of construction land in the west of Xingye Road and Qianjin Road, Shishan town, Nanhai District. According to the plan, the project party will build the park into a new biomedical industrial park focusing on epidemic prevention technology and integrating industry, University, research and government in five to eight years, becoming the core and leader of the biomedical industry in the Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Park of fobeizhan.
This is the third battle Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) leading project in Shishan town, Nanhai District in six days. Seizing the opportunity of opening the Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Park of fobeizhan, Shishan manufacturing accelerated the upgrading and iteration, focused on building the “two high and four new” industrial system, and rushed to the middle and high-end manufacturing.
Guangzhou Research Institute “overweight” Shishan
building a large health industry and epidemic prevention science and Technology Park
The great health industry and epidemic prevention science and Technology Park project is planned and operated by Guangzhou huri Pharmaceutical Technology Co., Ltd., an industry leader in the transformation and industrialization of industry, University and research achievements in China.
It is reported that relying on the production, study and research platform of academician Zhong Nanshan’s project team, Guangzhou huunitar Pharmaceutical Technology Co., Ltd. has formed the characteristics and development model of “talent achievement capital policy market”, and has established innovation platforms and industrial platforms such as Guangdong Engineering Laboratory, academician workstation, National Science and technology enterprise incubator (cultivation) and National University Science and Technology Park (cultivation), Direct investment has incubated more than 20 original technology enterprises that participate in and hold shares.
In 2018, Anjie Health Industrial Park, one of the two self built industrial parks under Guangzhou Hohhot Research Institute, laid the foundation in Shishan and “electrocuted” Shishan for the first time. Two years later, the first phase of the industrial park was settled.
It is this contact that makes Guangzhou Hohhot research institute more confident in its development in the South China Sea and Shishan. “We have good cooperation with the local government and are relatively consistent in concept and goal.” Wang Songzhang, executive deputy general manager of Guangzhou huunitar Medical Technology Co., Ltd. and general manager of Foshan Anjie Health Industry Co., Ltd., said that biomedicine has the characteristics of high technology, high investment, high risk, high return and long cycle, so the growth of the industry is inseparable from the strong cultivation and support of the government.
During the two-year contact, Nanhai District and Shishan town attached great importance to the biomedical industry. In 2020, Nanhai District signed an industry university cooperation framework agreement with Guangzhou Hohhot Research Institute to give strong support to the development of biomedical industry from many aspects. All the above are a major reason for Guangzhou Hohhot Research Institute to continue to increase investment here.
the estimated output value can reach 10 billion
leading enterprises drive to accelerate industrial agglomeration
It is reported that after obtaining the project land, the great health industry and epidemic prevention science and Technology Park project company – huunitar medical technology (Foshan) Co., Ltd. will invest 5 billion yuan. Relying on the scientific research platform of academician Zhong Nanshan’s team, it is planned to build a collection of Pharmaceutical Innovation Research Institute, epidemic prevention key technology innovation center, infection prevention and control engineering technology R & D center, Biomedical Innovation Center, vaccine production base The health industrial park of Jinan University of epidemic prevention science and technology, which integrates the R & D and production of genetically engineered drugs, the R & D and production of innovative drugs, the R & D and production of traditional Chinese medicine preparations, medical devices and special medical food production bases, is expected to have an output value of 10 billion yuan.
Biomedicine is one of the “two high and four new” industries in Shishan town. In 2020, the output value of biomedicine and medical equipment industry in Shishan town exceeded 4.4 billion yuan, and there were more than 100 oral equipment manufacturing enterprises in traditional advantageous industries.
Lily medical, langpeptide pharmaceutical, Dongfang Aolong, Jin Junkang and other enterprises have settled in Shishan town, and the construction of major innovation platforms such as Foshan Anjie Health Industrial Park, University Science Park of the Academy of Buddhist Sciences, translational medicine center of the Guangdong Academy of Medical Sciences and international technology transfer center is steadily advancing. There are dozens of incubating enterprises in Guangdong biomedical industry base, which is mainly built by Shishan.
“The development of biomedicine in Shishan has gradually become a climate. We hope to give full play to our influence, play a leading role, and attract more biomedical enterprises to gather in Shishan to form industrial clusters.” Wang Songzhang said that at present, more than a dozen biomedical enterprises have been introduced into Foshan Anjie Health Industrial Park under Guangzhou Hohhot Research Institute. “I believe that in three to five years, Shishan biomedical industry will become a potential and become an important industrial cluster in Shishan.”
introduce three leading projects within six days
Shishan manufacturing accelerated iteration and rushed to the middle and high end
On February 24, Foshan Zhongji Shimi new materials Co., Ltd., the leading enterprise of Shishan new energy materials, which filled the gap of Shanxi Guoxin Energy Corporation Limited(600617) materials in graphene fluid collection, signed the first order of the industrial land transfer contract for the opening of the Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Park in fobeizhan, and obtained 33 Mu of industrial land for the new and expanded 20000 t high-end fluid collection new material production base.
On February 28, Lingwang Elevator Co., Ltd. signed a land transfer contract, took about 95 mu of land in Shishan area of fubeizhan Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Park, and built a medium and high-end escalator industry upgrading base and technology R & D Center for R & D, design, testing and production of medium and high-end elevators, escalators and moving sidewalks, as well as key components and new products of elevators and escalators. According to the expectation, after the project is completed and put into operation, it is expected to produce 25000 sets of elevators and components per year, with an annual output value of 3 billion yuan. At that time, Lingwang elevator will contribute more than 4 billion yuan of output value to Shishan every year.
On March 1, the great health industry and epidemic prevention science and Technology Park project was launched.
Within six days, Shishan sold nearly 370 mu of land to introduce the new industry leader of World War III into the Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Park of fobeizhan. Among the 47 district level major projects in Shishan town in 2022 released on February 28, there are 37 industrial projects, accounting for nearly 80%.
Taking the opportunity of the opening of fubeizhan Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Park, Shishan manufacturing is accelerating its iteration and moving towards medium and high-end manufacturing.
